CETYLPYRIDINIUM CHLORIDE

N/A

Manufactured by RB Health (US) LLC

1,541 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CETYLPYRIDINIUM CHLORIDE

CETYLPYRIDINIUM CHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by RB Health (US) LLC. The most commonly reported adverse reactions for CETYLPYRIDINIUM CHLORIDE include DYSPNOEA, NAUSEA, PAIN, FATIGUE, COUGH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CETYLPYRIDINIUM CHLORIDE.

Top Adverse Reactions

DYSPNOEA49 reports
NAUSEA45 reports
PAIN41 reports
FATIGUE39 reports
COUGH32 reports
VOMITING32 reports
AGEUSIA31 reports
SEPSIS29 reports
ORAL PAIN27 reports
TOOTH DISCOLOURATION27 reports
ASTHENIA26 reports
PNEUMONIA26 reports
DEATH25 reports
DIZZINESS25 reports
OFF LABEL USE25 reports
ORAL DISCOMFORT25 reports
DIARRHOEA23 reports
DYSGEUSIA23 reports
ARTHRALGIA22 reports
DRUG INEFFECTIVE22 reports
BACK PAIN21 reports
CONSTIPATION20 reports
ERYTHEMA20 reports
RASH20 reports
HEADACHE19 reports
PYREXIA19 reports
ACUTE KIDNEY INJURY18 reports
ABDOMINAL PAIN17 reports
CONDITION AGGRAVATED17 reports
ABDOMINAL DISCOMFORT16 reports
WEIGHT DECREASED16 reports
ANAEMIA15 reports
PRURITUS15 reports
SWELLING FACE15 reports
DYSPHAGIA14 reports
DYSPHONIA14 reports
INSOMNIA14 reports
JOINT SWELLING14 reports
STOMATITIS14 reports
URINARY TRACT INFECTION14 reports
COVID 1913 reports
DRY SKIN13 reports
HYPERSENSITIVITY13 reports
HYPOAESTHESIA13 reports
NASOPHARYNGITIS13 reports
PLATELET COUNT DECREASED13 reports
RENAL FAILURE13 reports
CHRONIC KIDNEY DISEASE12 reports
DRUG HYPERSENSITIVITY12 reports
DRY MOUTH12 reports
FEBRILE NEUTROPENIA12 reports
GLOSSODYNIA12 reports
LOSS OF CONSCIOUSNESS12 reports
PAIN IN EXTREMITY12 reports
RHINORRHOEA12 reports
SNEEZING12 reports
SWOLLEN TONGUE12 reports
CONTUSION11 reports
DEEP VEIN THROMBOSIS11 reports
EAR PAIN11 reports
GAIT DISTURBANCE11 reports
GINGIVAL PAIN11 reports
MALAISE11 reports
NASAL CONGESTION11 reports
THROAT IRRITATION11 reports
THROMBOCYTOPENIA11 reports
ANAPHYLACTIC REACTION10 reports
DECREASED APPETITE10 reports
FALL10 reports
FEELING ABNORMAL10 reports
HYPERTENSION10 reports
LIP SWELLING10 reports
METASTASES TO LYMPH NODES10 reports
MYALGIA10 reports
ORAL MUCOSAL EXFOLIATION10 reports
URTICARIA10 reports
WEIGHT INCREASED10 reports
WHEEZING10 reports
CHEST PAIN9 reports
HYPOAESTHESIA ORAL9 reports
INFECTION9 reports
PERIPHERAL SWELLING9 reports
PULMONARY EMBOLISM9 reports
THROAT TIGHTNESS9 reports
TONGUE DISORDER9 reports
WHITE BLOOD CELL COUNT DECREASED9 reports
WOUND9 reports
BLISTER8 reports
CHILLS8 reports
DENTAL CARIES8 reports
ECZEMA8 reports
HAEMOGLOBIN DECREASED8 reports
HYPOTENSION8 reports
INFLUENZA8 reports
INJURY8 reports
MOUTH ULCERATION8 reports
OEDEMA8 reports
PALPITATIONS8 reports
PLEURAL EFFUSION8 reports
PSEUDOMONAL SEPSIS8 reports

Report Outcomes

Out of 628 classified reports for CETYLPYRIDINIUM CHLORIDE:

Serious 79.3%Non-Serious 20.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female375 (63.9%)
Male210 (35.8%)
Unknown2 (0.3%)

Reports by Age

Age 6822 reports
Age 6619 reports
Age 6714 reports
Age 6913 reports
Age 5811 reports
Age 5911 reports
Age 6111 reports
Age 7411 reports
Age 7010 reports
Age 7810 reports
Age 519 reports
Age 579 reports
Age 609 reports
Age 769 reports
Age 819 reports
Age 308 reports
Age 458 reports
Age 488 reports
Age 508 reports
Age 628 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CETYLPYRIDINIUM CHLORIDE?

This profile reflects 1,541 FDA FAERS reports that mention CETYLPYRIDINIUM CHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CETYLPYRIDINIUM CHLORIDE?

Frequently reported terms in FAERS include DYSPNOEA, NAUSEA, PAIN, FATIGUE, COUGH, VOMITING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CETYLPYRIDINIUM CHLORIDE?

Labeling and FAERS entries often list RB Health (US) LLC in connection with CETYLPYRIDINIUM CHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.